Status:
TERMINATED
A Study of MK0594 in Patients With Alcohol Dependence (0594-020)
Lead Sponsor:
Vyne Therapeutics Inc.
Conditions:
Alcohol Dependence
Eligibility:
All Genders
21+ years
Phase:
PHASE2
Brief Summary
A study in patients with alcohol dependence to see if MK0594 is safe and effective in maintaining absence of heavy drinking over a 12-week treatment period.
Eligibility Criteria
Inclusion
- Patient has Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision diagnosis of alcohol dependence and alcohol addiction
- Patient has two heavy drinking days in the last 30 days
- Patient has 3 days of abstinence from alcohol right before taking study medication
- Patient has lived in the same residence for the last 2 months
Exclusion
- If female, patient is pregnant or breastfeeding
- Patient anticipated inpatient alcohol treatment
- Patient has a history of suicide attempt in the last year
- Patient has schizophrenia or bipolar disorder
- Patient has a history of multiple or serious allergies
- Patient has participated in a clinical trial in the last 30 days
Key Trial Info
Start Date :
February 27 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 11 2010
Estimated Enrollment :
162 Patients enrolled
Trial Details
Trial ID
NCT00835718
Start Date
February 27 2009
End Date
March 11 2010
Last Update
May 20 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.